Akura Immune Flow Chip microfluidic 3D spheroid system

19 April 2024

Cancer metastatic potential refers to the propensity of cancer cells to spread from their original site to distant organs or tissues in the body, often influencing disease progression and treatment outcomes. InSphero AG, in collaboration with various institutions, introduces the Akura Immune Flow Platform, a pump-free system designed for studying the flow-dependent recruitment of circulating cells to microtissues. By co-culturing human liver and bone microtissues with prostate cancer cell lines under different tilting parameters, the platform allows for the assessment of cancer metastatic potential and immune cell infiltration.